5 results match your criteria: "Chongqing Liangping District People's Hospital[Affiliation]"
Trials
April 2024
Department of Anesthesiology, The Research Units of West China (2018RU012), West China Hospital, Sichuan University, Chinese Academy of Medical Sciences, Chengdu, 610041, China.
Background: Breast cancer is the most prevalent cancer among women globally, and surgical procedures continue to be the primary treatment. However, over 50% of patients experience preoperative anxiety due to the unknown and fear associated with surgery. Although drug therapy is commonly used to address this anxiety, its side effects have led to a heated debate regarding its effectiveness.
View Article and Find Full Text PDFBioorg Chem
June 2023
Chongqing Liangping District People's Hospital, Chongqing 405200, China. Electronic address:
ROR1 and Aurora kinase were overexpressed in various cancers and essential for cell proliferation, survive and metastasis. Pharmaceutical inhibition of ROR1 and Aurora kinase abrogated the activation of downstream signaling and induced cancer cell apoptosis. Hence, ROR1 and Aurora kinase considered as attractive therapeutic targets for the development of anticancer drugs.
View Article and Find Full Text PDFJ Multidiscip Healthc
January 2023
Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Purpose: The National Remote Emergency System for Malignant Hyperthermia (MH-NRES) is an applet in China, designed to help anesthesiologists manage MH crisis. However, there is limited information about encountered difficulties in dealing with MH among Chinese anesthesiologists. The purpose of the study was to explore the current competency and encountered difficulties in the management of MH, as a key first step for assessing the potential user needs to develop the MH-NRES.
View Article and Find Full Text PDFJ Multidiscip Healthc
December 2022
Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Purpose: Malignant hyperthermia (MH) is a rare but fatal pharmacogenetic disorder, triggered by inhalational anesthetics or succinylcholine. Since the first nonprofit academic organization China Malignant Hyperthermia Emergency Assistance WeChat-based Group (CMHEA Group) was established in 2015, they have actively participated in the diagnosis and treatment of MH patients. Based on the CMHEA Group, the aim of the study was to retrospectively analyze the characteristics of suspected MH in China from 2015 to 2020.
View Article and Find Full Text PDFFront Med (Lausanne)
May 2022
Department of Nephrology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Sepsis-associated acute kidney injury (SA-AKI) is common in patients with severe sepsis, and has a high incidence rate and high mortality rate in ICU patients. Most patients progress to AKI before drug treatment is initiated. Early studies suggest that the main mechanism of SA-AKI is that sepsis leads to vasodilation, hypotension and shock, resulting in insufficient renal blood perfusion, finally leading to renal tubular cell ischemia and necrosis.
View Article and Find Full Text PDF